Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.

McGhee P, Clark C, Kosowska-Shick KM, Nagai K, Dewasse B, Beachel L, Appelbaum PC.

Antimicrob Agents Chemother. 2010 Jan;54(1):230-8. doi: 10.1128/AAC.01123-09. Epub 2009 Nov 2.

2.

Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.

Kosowska-Shick K, Clark C, Pankuch GA, McGhee P, Dewasse B, Beachel L, Appelbaum PC.

Antimicrob Agents Chemother. 2009 Oct;53(10):4217-24. doi: 10.1128/AAC.00742-09. Epub 2009 Jul 20.

3.

Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains.

Clark C, Kosowska-Shick K, McGhee P, Dewasse B, Beachel L, Appelbaum PC.

Antimicrob Agents Chemother. 2009 Jul;53(7):3118-21. doi: 10.1128/AAC.00183-09. Epub 2009 May 11.

4.

Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs.

Clark C, Ednie LM, Lin G, Smith K, Kosowska-Shick K, McGhee P, Dewasse B, Beachel L, Caspers P, Gaucher B, Mert G, Shapiro S, Appelbaum PC.

Antimicrob Agents Chemother. 2009 Apr;53(4):1353-61. doi: 10.1128/AAC.01619-08. Epub 2009 Feb 2.

5.

In vitro capability of faropenem to select for resistant mutants of Streptococcus pneumoniae and Haemophilus influenzae.

Kosowska-Shick K, Clark C, Credito K, Dewasse B, Beachel L, Ednie L, Appelbaum PC.

Antimicrob Agents Chemother. 2008 Feb;52(2):748-52. Epub 2007 Dec 17.

6.

In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci.

Clark C, Smith K, Ednie L, Bogdanovich T, Dewasse B, McGhee P, Appelbaum PC.

Antimicrob Agents Chemother. 2008 Jan;52(1):77-84. Epub 2007 Oct 15.

7.

Antistaphylococcal activity of CG400549, a new experimental FabI inhibitor, compared with that of other agents.

Bogdanovich T, Clark C, Kosowska-Shick K, Dewasse B, McGhee P, Appelbaum PC.

Antimicrob Agents Chemother. 2007 Nov;51(11):4191-5. Epub 2007 Sep 17.

8.

Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents.

Kosowska-Shick K, Credito KL, Pankuch GA, DeWasse B, McGhee P, Appelbaum PC.

Antimicrob Agents Chemother. 2007 Feb;51(2):770-3. Epub 2006 Nov 20.

9.

Activity of LBM415 compared to those of 11 other agents against Haemophilus species.

Bogdanovich T, Smith KA, Clark C, Pankuch GA, Lin G, McGhee P, Dewasse B, Appelbaum PC.

Antimicrob Agents Chemother. 2006 Jul;50(7):2323-9.

10.

Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.

Kosowska-Shick K, Credito K, Pankuch GA, Lin G, Bozdogan B, McGhee P, Dewasse B, Choi DR, Ryu JM, Appelbaum PC.

Antimicrob Agents Chemother. 2006 Jun;50(6):2064-71.

11.

Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes.

Kosowska-Shick K, Clark C, Credito K, McGhee P, Dewasse B, Bogdanovich T, Appelbaum PC.

Antimicrob Agents Chemother. 2006 Feb;50(2):765-9.

12.

Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporin.

Kosowska K, Hoellman DB, Lin G, Clark C, Credito K, McGhee P, Dewasse B, Bozdogan B, Shapiro S, Appelbaum PC.

Antimicrob Agents Chemother. 2005 May;49(5):1932-42.

13.

Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.

Kosowska K, Credito K, Pankuch GA, Hoellman D, Lin G, Clark C, Dewasse B, McGhee P, Jacobs MR, Appelbaum PC.

Antimicrob Agents Chemother. 2004 Nov;48(11):4113-9.

14.

In vitro selection of resistance in haemophilus influenzae by 4 quinolones and 5 beta-lactams.

Clark C, Kosowska K, Bozdogan B, Credito K, Dewasse B, McGhee P, Jacobs MR, Appelbaum PC.

Diagn Microbiol Infect Dis. 2004 May;49(1):31-6.

PMID:
15135497
15.

Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agents.

Browne FA, Bozdogan B, Clark C, Kelly LM, Ednie L, Kosowska K, Dewasse B, Jacobs MR, Appelbaum PC.

Antimicrob Agents Chemother. 2003 Dec;47(12):3815-24.

16.

Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin.

Browne FA, Clark C, Bozdogan B, Dewasse BE, Jacobs MR, Appelbaum PC.

Int J Antimicrob Agents. 2002 Aug;20(2):93-9.

PMID:
12297357
17.

In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin.

Clark C, Bozdogan B, Peric M, Dewasse B, Jacobs MR, Appelbaum PC.

Antimicrob Agents Chemother. 2002 Sep;46(9):2956-62.

18.

Activity of cefditoren against respiratory pathogens.

Clark CL, Nagai K, Dewasse BE, Pankuch GA, Ednie LM, Jacobs MR, Appelbaum PC.

J Antimicrob Chemother. 2002 Jul;50(1):33-41.

PMID:
12096004
19.

Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin.

Clark CL, Nagai K, Davies TA, Bozdogan B, Dewasse B, Jacobs MR, Appelbaum PC.

Clin Microbiol Infect. 2002 Jun;8(6):373-80.

20.
21.

In vitro development of resistance to ceftriaxone, cefprozil and azithromycin in Streptococcus pneumoniae.

Nagai K, Davies TA, Dewasse BE, Pankuch GA, Jacobs MR, Appelbaum PC.

J Antimicrob Chemother. 2000 Dec;46(6):909-15.

PMID:
11102409
22.

In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae.

Nagai K, Davies TA, Pankuch GA, Dewasse BE, Jacobs MR, Appelbaum PC.

Antimicrob Agents Chemother. 2000 Oct;44(10):2740-6.

23.
24.

In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae.

Davies TA, Pankuch GA, Dewasse BE, Jacobs MR, Appelbaum PC.

Antimicrob Agents Chemother. 1999 May;43(5):1177-82.

Supplemental Content

Loading ...
Support Center